Whale Analyzer
SEC 13F · Available

John Paulson 13F Holdings

Paulson & Co. Famous for the greatest trade ever (2008 subprime). John Paulson became a billionaire by using credit default swaps to short the US housing market before the 2008 financial crisis, a trade chronicled in the book 'The Greatest Trade Ever'.

As of the latest Q1 2026 filing, John Paulson (managing Paulson & Co) reported a public portfolio value of $3.1B with 9 positions. The top recent buy was THM. The top recent sell was MDGL.

Open interactive portfolio
$3.1BPortfolio value
9Holdings
Q1 2026Latest quarter
2026-05-15Filing date

John Paulson 13F portfolio overview

John Paulson's Q1 2026 13F holdings show Paulson & Co reporting 9 positions with a disclosed portfolio value of $3.1B. For readers searching John Paulson 13F holdings, John Paulson portfolio, or Paulson & Co holdings, the latest top holdings include PERPETUA RESOURCES, MADRIGAL PHARMACEUTICALS, ACADIAN ASSET MANAGEMENT, BAUSCH HEALTH COS, and NOVAGOLD RESOURCES.

The three largest reported positions add up to roughly 66.2%, which helps readers judge portfolio concentration rather than just headline AUM. The largest reported sector exposure is Energy at 37.1% of the disclosed portfolio. This makes the page useful for comparing the manager's actual disclosed exposure with market narratives around the same names.

The latest change data highlights reported buys such as INTERNATIONAL TOWER HILL MIN, THRYV HLDGS, and AMICUS THERAPEUTIC and reported reductions or exits such as MADRIGAL PHARMACEUTICALS and SOLSTICE ADVANCED MATLS. Those changes should be read as historical disclosure signals, not as real-time trade alerts.

The filing metadata lists report date 2026-03-31, filing date 2026-05-15, SEC accession 0001013594-26-000611. SEC 13F reports are normally published up to 45 days after quarter end, so the data is best used to understand institutional positioning after the fact rather than to infer today's exact portfolio.

Top reported holdings

HoldingReported valueWeightQuarter change
PPTA whale holders
PERPETUA RESOURCES CORP
$909.6M29.2%Held
MDGL whale holders
MADRIGAL PHARMACEUTICALS INC
$728.8M23.4%Reduced
AAMI whale holders
ACADIAN ASSET MANAGEMENT INC
$421.4M13.5%Held
BHC whale holders
BAUSCH HEALTH COS INC
$395.6M12.7%Held
NG whale holders
NOVAGOLD RESOURCES INC
$244.6M7.9%Held
THM whale holders
INTERNATIONAL TOWER HILL MIN
$229.0M7.4%Increased
AEM whale holders
AGNICO EAGLE MINES LTD
$159.0M5.1%Held
THRY whale holders
THRYV HLDGS INC
$23.1M0.7%Increased
FOLD whale holders
AMICUS THERAPEUTIC
$468.5K0.0%New

Top buys

Top sells

Allocation

  • Energy: 37.1%
  • Health Care: 36.1%
  • Industrials: 13.5%
  • Other: 8.1%
  • Materials: 5.1%

Data notes

Report date: 2026-03-31

Disclosure source: SEC 13F

13F filings are delayed public disclosures and do not include every asset class, short positions, or real-time trades.

This page is generated from public filings and public disclosures. It is for research and education only and is not investment advice.

Related investor portfolios

Learn more in Whale Analyzer Academy

Frequently asked questions

What is John Paulson buying?

The latest tracked change data for John Paulson highlights reported buys such as INTERNATIONAL TOWER HILL MIN, THRYV HLDGS, and AMICUS THERAPEUTIC. Because 13F data is historical, use it as a research trail rather than a live trade alert.

John Paulson 13F portfolio

The Q1 2026 SEC 13F profile for John Paulson and Paulson & Co shows 9 reported positions, $3.1B in disclosed portfolio value, and top holdings including PERPETUA RESOURCES, MADRIGAL PHARMACEUTICALS, ACADIAN ASSET MANAGEMENT, BAUSCH HEALTH COS, and NOVAGOLD RESOURCES.

Paulson & Co holdings

Paulson & Co holdings are summarized from public disclosures with reported values, weights, top buys, top sells, and filing metadata where available.

How delayed is John Paulson's 13F data?

SEC Form 13F requires institutional investment managers with $100M+ in US equities to disclose their holdings quarterly. Read our comprehensive 13F guide.